ACON
Aclarion, Inc.·Healthcare
3.23
7.714%(−0.27)
Market ClosedLast Updated: — ET
52W L: $2.3452W H: $12.03
ACON NEWS
prismmediawire.com
3d ago
Aclarion Announces Agreement with Weill Cornell Medicine
Expands use of Nociscan in groundbreaking trial Broomfield, CO, April 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
globenewswire.com
3d ago
Aclarion Announces Agreement with Weill Cornell Medicine
BROOMFIELD, Colo., April 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today it has established a commercial agreement with Weill Cornell Medicine.
globenewswire.com
4d ago
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Video featuring Mr. John Sutcliffe, Lead Clinician at The London Spine Clinic, highlights real-world physician experience with Nociscan in clinical practice Nearly 100 Nociscans performed at The London Clinic, reflecting increasing utilization for evaluation of chronic low back pain BROOMFIELD, Colo.
defenseworld.net
Mar 28
Todos Med (OTCMKTS:TOMDF) and Aclarion (NASDAQ:ACON) Head-To-Head Survey
Aclarion (NASDAQ: ACON - Get Free Report) and Todos Med (OTCMKTS:TOMDF - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Institutional and Insider Ownership 7.5% of Aclarion shares are
accessnewswire.com
Mar 24
Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc.
Stock has declined 99% since its IPO Believes Neal has repeatedly failed to fulfill his fiduciary responsibility Since 2021 Neal has received $240,000 Board compensation Accepted 20% pay increase in 2025 despite the company and shareholders suffering losses Believes Neal lacks appropriate skill set to serve on the Board Despite being on the Board for 9 years, Neal owns only two shares with a total market value of $6.24. Recently further entrenched himself with anti-takeover measures Questions employment of Jeff Thramann Believes Board could easily create meaningful shareholder value Notes stock trades below its net cash NEW YORK, NY / ACCESS Newswire / March 24, 2026 / Earlier today Ephraim Fields of Echo Lake Capital sent a letter to David K.
prismmediawire.com
Mar 19
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
BROOMFIELD, Colo., March 19, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc. (Nasdaq: ACON, ACONW) (“Aclarion” or the “Company”) today announced that its Board of Directors (the “Board”) has unanimously adopted a limited duration stockholder rights plan (the “Rights Plan”).
